AlphaYouMD
Insider selling
Mittie Doyle sold $26K of Avalo Therapeutics, Inc. (AVTX) stock
Mittie Doyle, Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX), sold 1,450 shares of AVTX stock worth $26K, per an SEC Form 4 filed Jun 25, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 23, 2026, 2 days before it was made public.
AVTX has moved -7.1% since the trade date, from $17.83 to $16.57 (Sep 18, 2026 close).
- Traded
- Jun 23, 2026
- Disclosed
- Jun 25, 2026
- Filing delay
- 2 days
- Price since
- -7.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More AVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.